Coral Laboratories Limited

BSE:524506 Stock Report

Market Cap: ₹2.6b

Coral Laboratories Past Earnings Performance

Past criteria checks 4/6

Coral Laboratories has been growing earnings at an average annual rate of 14.7%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 2.5% per year. Coral Laboratories's return on equity is 11.4%, and it has net margins of 20.9%.

Key information

14.7%

Earnings growth rate

14.7%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate2.5%
Return on equity11.4%
Net Margin20.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Coral Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:524506 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,1082311480
30 Jun 241,0182281260
31 Mar 248371581210
31 Dec 23662911060
30 Sep 23729781060
30 Jun 23754671080
31 Mar 23781641130
31 Dec 22868991210
30 Sep 22754931190
30 Jun 22681481120
31 Mar 22756901180
31 Dec 21834821430
30 Sep 219841261430
30 Jun 219811411100
31 Mar 219661361260
31 Dec 208931531090
30 Sep 208091291060
30 Jun 207921201070
31 Mar 20706711110
31 Dec 19693251150
30 Sep 19729331140
30 Jun 1982070970
31 Mar 199111021160
31 Dec 189681441110
30 Sep 189241341110
30 Jun 18967141930
31 Mar 189251241000
31 Dec 17904137830
30 Sep 17960166770
30 Jun 17902153700
31 Mar 17904163710
31 Dec 16883157640
30 Sep 16836138600
30 Jun 16801126550
31 Mar 16770124520
31 Dec 15718114910
30 Sep 15658112890
30 Jun 15628108440
31 Mar 1559496430
31 Dec 1455688620
30 Sep 1453276600
30 Jun 1450674590
31 Mar 1450879680
31 Dec 1347779640

Quality Earnings: 524506 has a high level of non-cash earnings.

Growing Profit Margin: 524506's current net profit margins (20.9%) are higher than last year (10.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 524506's earnings have grown by 14.7% per year over the past 5 years.

Accelerating Growth: 524506's earnings growth over the past year (196.1%) exceeds its 5-year average (14.7% per year).

Earnings vs Industry: 524506 earnings growth over the past year (196.1%) exceeded the Pharmaceuticals industry 20.4%.

Return on Equity

High ROE: 524506's Return on Equity (11.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 16:53
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Coral Laboratories Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bikshapathi A.FirstCall Research